Suchergebnisse - "Cervantes, A"

PubPharm (7)

1

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

enthalten in: British journal of cancer | 2016

von Elez, E. | Hendlisz, A. | Delaunoit, T. | +6

2

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer : results of the EXPERT-C trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Sclafani, F. | Chau, I. | Cunningham, D. | +16

3

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Sclafani, F. | Roy, A. | Cunningham, D. | +9

4

Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab : a TTD group cooperative study

enthalten in: PloS one | 2012

von Díaz-Rubio, E. | Gómez-España, A. | Massutí, B. | +71

5

FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level : an exploratory cohort of the GERCOR OPTIMOX1 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2009

von Chibaudel, B. | Tournigand, C. | Artru, P. | +12

6

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2009

von Bidard, F. | Tournigand, C. | André, T. | +8

7

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2000

von de Gramont, A. | Figer, A. | Seymour, M. | +15

RepublishedIn: J Clin Oncol. 2023 Nov 20;41(33):5080-5089. - PMID 37967516

1
[1]